NCT00287027View on ClinicalTrials.gov

Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication

TerminatedOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

December 31, 2006

Conditions

Psychotic Disorders

Interventions

DRUG

Risperdal Long Acting Injectable Antipsychotic Medication

Trial Locations (1)

03301

NAMI NH, Concord

Sponsors

Collaborators (1)

Janssen Medical Affairs

All Listed Sponsors

collaborator

Janssen Medical Affairs

INDUSTRY

lead

National Alliance on Mental Illness New Hampshire

OTHER